The Problem
A next-generation sequencing platform entered development during a period of organizational transition. The program had recently moved from one leader to another, several team members were new, and the rationale behind earlier product decisions had not been preserved.
As a result, the team was carrying forward inherited assumptions that no one could clearly justify. Some features had become embedded in the design simply because they were already there. They added cost, complexity, and development burden, but were not clearly connected to user needs, workflow performance, or launch success.
At the same time, marketing was a major voice in the room, but there was no effective translation layer between market expectations and development realities. The development team understood where complexity was accumulating, but that perspective was not consistently being translated into language marketing could use to make prioritization decisions.
Several stakeholders were also treating the competitor's product as the gold standard. But the competitor workflow was burdening customers with unnecessary complexity. By copying that model too closely, the team risked recreating the same customer friction instead of using better early architecture to outdo the competition without adding development scope.
The result was a familiar pattern: apparent alignment in meetings, followed by reopened decisions as teams returned to their own workstreams and interpreted priorities differently.
Alignment Approach
Led cross-functional strategic alignment across assay development, automation, software, bioinformatics, operations, marketing, and product stakeholders. The work focused on pressure-testing inherited assumptions and converting fragmented input into a shared Minimum Viable Product (MVP) strategy that teams could execute against.
"The work succeeded because the focus was not simply on reaching agreement. The focus was reaching agreement on the right scope."
- Reconstructed the rationale behind prior product and architecture decisions
- Challenged inherited features and descoped those that lacked clear justification
- Created a shared framework for evaluating launch-critical versus non-critical functionality
- Translated development tradeoffs into business, market, user, and operational implications
- Reframed competitive strategy around customer value rather than feature matching
- Exposed hidden dependencies across hardware, software, assay, data, and workflow decisions
- Drove convergence around product-defining architecture choices
Outcomes
- Resolved product-defining decisions across 30+ cross-functional stakeholders
- Locked MVP scope around the requirements most critical to user needs and operational success
- Descoped 11 non-critical features to reduce cost, complexity, and timeline pressure
- Created clearer translation between marketing priorities and development realities
- Established a shared decision framework grounded in system-level tradeoffs rather than inherited assumptions
- Secured executive phase-gate approval to proceed
Why This Worked
The work succeeded because the focus was not simply on reaching agreement. The focus was reaching agreement on the right scope. Rather than simply documenting requirements or optimizing individual components, the engagement helped the organization identify which decisions mattered, which assumptions were inherited but unproven, and which features created unnecessary burden without improving the user experience.
By reconnecting MVP scope to user needs, operational reality, and system-level tradeoffs, the program reduced scope churn, improved decision velocity, and established a cleaner path from early development to scalable deployment.
The team did not need to match the competitor feature for feature. It needed to understand where the competitor had created friction, then use better early architecture to deliver a simpler, more usable system.